Table 1

Differentially expressed genes in the 2 studies

CNS to non-CNSSymbolRubenstein study
Tun study
Fold changePFold changeP
Up-regulated      
    Osteopontin SPP1 11.4 8.00 × 10−6 9.73 3.03 × 10−8 
    Complement component 1, q, subcomponent C1QB 2.8 8.29 × 10−6 2.40 × 10−2 
    Hemoglobin, alpha2 HBA2 6.26 × 10−4 2.5 1.90 × 10−2 
    Regulator of G-protein signaling 13 RGS13 2.3 3.34 × 10−2 2.4 2.70 × 10−2 
    Chitinase 3-like 1 CH13L1 2.8 5.02 × 10−2 2.72 5.10 × 10−5 
VT-cell leukemia/lymphoma 1A TCL1A 2.8 1.07 × 10−1 2.96 5.55 × 10−5 
Down-regulated      
    Nicotinamide N-methyltransferase NNMT 0.56 5.26 × 10−3 0.43 8.99 × 10−4 
    Vascular endothelial growth factor C VEGFS 0.51 7.16 × 10−3 0.4 1.00 × 10−3 
    Collagen, type VI. alpha 1 COL6A1 0.45 1.32 × 10−2 0.45 3.25 × 10−4 
    Latexin LXN 0.76 1.99 × 10−2 0.48 2.67 × 10−2 
    Lumican LUM 0.5 2.27 × 10−2 0.28 8.45 × 10−3 
    Laminin, alpha 4 LAMA4 0.74 4.54 × 10−2 0.37 8.00 × 10−3 
CNS to non-CNSSymbolRubenstein study
Tun study
Fold changePFold changeP
Up-regulated      
    Osteopontin SPP1 11.4 8.00 × 10−6 9.73 3.03 × 10−8 
    Complement component 1, q, subcomponent C1QB 2.8 8.29 × 10−6 2.40 × 10−2 
    Hemoglobin, alpha2 HBA2 6.26 × 10−4 2.5 1.90 × 10−2 
    Regulator of G-protein signaling 13 RGS13 2.3 3.34 × 10−2 2.4 2.70 × 10−2 
    Chitinase 3-like 1 CH13L1 2.8 5.02 × 10−2 2.72 5.10 × 10−5 
VT-cell leukemia/lymphoma 1A TCL1A 2.8 1.07 × 10−1 2.96 5.55 × 10−5 
Down-regulated      
    Nicotinamide N-methyltransferase NNMT 0.56 5.26 × 10−3 0.43 8.99 × 10−4 
    Vascular endothelial growth factor C VEGFS 0.51 7.16 × 10−3 0.4 1.00 × 10−3 
    Collagen, type VI. alpha 1 COL6A1 0.45 1.32 × 10−2 0.45 3.25 × 10−4 
    Latexin LXN 0.76 1.99 × 10−2 0.48 2.67 × 10−2 
    Lumican LUM 0.5 2.27 × 10−2 0.28 8.45 × 10−3 
    Laminin, alpha 4 LAMA4 0.74 4.54 × 10−2 0.37 8.00 × 10−3 
Close Modal

or Create an Account

Close Modal
Close Modal